A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients

Clinical trial NCT02578641 · COMPLETED

Trial details

NCT number: NCT02578641
Sponsor: Tessa Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2014-07-01
Primary completion: 2022-02-28
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.